Key facts
- Notable investors include Clerisy (USA), Clerisy Global Capital Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Eudēmonia Summit
- ·The full record, as it builds
Funding rounds
No funding rounds for Eudēmonia Summit are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eudēmonia Summit
Provider of a science-based health summit intended to promote preventative medicine, regenerative health, and holistic well-being through expert-led sessions, workouts, and wellness expos. The company offers on-site biometric testing and curated experiential sessions, enabling health seekers, practitioners, and industry leaders to optimize their mental and physical health using science-backed tools.
- Sector
- Healthcare
- HQ
- Hollis, NH, United States
- Founded
- 2023
- Employees
- 20
- Website
- eudemonia.net/
- Ownership
- Privately Held (backing)
Eudēmonia Summit doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eudēmonia Summit shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eudēmonia Summit in its N-PORT filings yet. We sweep new filings monthly.